The Roche group has reached an agreement to acquire Anadys Pharmaceuticals Inc for $230 million in order to expand its franchise in treatments for hepatitis C virus (HCV) infections. Anadys is located in San Diego, California. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
